Taylor Financial Group, Inc. Q4 2025 Filing

Filed February 6, 2026

Portfolio Value

$170.2M

Holdings

102

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (102 positions)

#StockSharesValue% PortfolioType
101
CADLCANDEL THERAPEUTICS INC
13,600$76K0.04%
102
MISTMILESTONE PHARMACEUTICALS IN
10,000$20K0.01%
PreviousPage 2 of 2